Events By Year
- Supply chain and logistics
- 8th Jan, 2021 11:00 - UTC
This is an 11-month online program that includes 9 extensive modules structured to address one topic per month. Each module is supported by MCQ's and Assessments.
Key Takeaway's from the course:
- its global orientation ¬ sharing of experiences from across countries,
- a practical and applied approach to the extensive use of exercises, case studies, projects, and internships
- technical assistance for one-year offered which includes Mentoring/Coaching from the Subject Matter Experts
- an online competency assessment tool (CAT)
- a community of practice (through Empower’s Big Learning Platform)
- a special focus on improving participant's personal effectiveness by building workplace skills
- use of cutting-edge e-learning technologies and instructional design to make learning easy and impactful
Kindly click on this link for more information and fill in the application form to register - http://bit.ly/2UzLGnf
- Global initiatives
- Group Event
- 21st Jan, 2021 09:00 - Europe/Brussels
PATH, in collaboration with TechNet-21, the East African Community (EAC) Immunitzation Group, and The Vaccine Procurement Practitioners Network (VPPN), are delighted to invite you to join a webinar on using PATH's Vaccine Cost Calculators to inform immunization decision-making.
Webinar title: Using PATH’s Vaccine Cost Calculators to inform immunization decision-making
Description: For country-level policymakers, the opportunity to introduce a new vaccine comes with many considerations. Is the vaccine needed? What are the benefits? Is there enough capacity in the cold chain system? Often most important—what will it cost, and can our country afford it? Adding complexity to complexity, new vaccine products and new formulations of existing vaccines continue to be developed and commercialized, which can make decisions more daunting when a country is choosing which vaccine product to introduce or switch to. PATH’s new Vaccine Cost Calculators can help, providing an easy way for country-level decision-makers to assess and compare the costs of certain vaccination programs over a period of 10 years with each vaccine product available in the global market. These Excel-based tools are currently available in English, French, Russian, and Spanish for rotavirus vaccines and pneumococcal conjugate vaccines. A calculator for human papillomavirus vaccines is coming in 2021, with potentially more to follow. PATH’s Frédéric Debellut will share the rationale and process behind the development of these tools and provide a demonstration of how to actually use the tools, allowing lots of time for questions and comments from webinar participants.
Speaker bio: Frédéric Debellut is a senior health economist at PATH’s Center for Vaccine Innovation and Access. He is responsible for the design and conduct of economic analyses with the objective to generate and translate economic evidence that informs donor investments, global policy, and country vaccine introduction decisions. His work encompasses cost of delivery and cost-effectiveness studies, budget impact analyses, and demand forecasting, and focuses on vaccines against rotavirus, typhoid, human papillomavirus, meningitis A, and seasonal influenza.
- 25th Jan, 2021 12:00 - UTC
The International Pediatric Association in collaboration with Sabin Vaccine Institute is pleased to invite you for a webinar on "Covid-19 and Immunization: Challenges facing health workers in Eastern Europe"`
- Cold chain equipment
- 26th Jan, 2021 13:00 - 14:00 - UTC
Please join JSI Research & Training, Inc. for the last webinar in the Ensuring a Responsive Immunization Supply Chain series, Managing the Inventory of Cold Chain Equipment.
By the end of the webinar, participants will be able to:
1. Describe a process for planning CCE needs
2. List the information needed when managing the inventory of CCE
3. Identify tools to facilitate the management of CCE inventory
To register, follow this link
- 29th Jan, 2021 15:00 - UTC
About this Event
This Knight Center webinar, which will take place on Friday, January 29, from 9 a.m to 12 p.m. Central Standard Time, will be held in partnership with UNESCO and the World Health Organization. The webinar will be broken into three, one-hour panels, each of which will be moderated by renowned health and science journalist Maryn McKenna.
• From 9 to 10 a.m. CST, we’ll hear from five journalists who will share their experiences covering vaccines internationally. They’ll discuss what constitutes good vaccine coverage and will share related best practices. Speakers include science journalists Andre Biernath from Brazil, Federico Kukso from Argentina, Kai Kupferschmidt from Germany, and Yves Sciama from France.
• From 10 to 11 a.m. CST, we’ll explore key scientific developments behind the vaccines, with an eye toward helping journalists understand the global significance of these developments. Speakers include the World Health Organization’s Kate O’Brien, immunologist Purvi Parikh, and coronavirologist Angela Rasmussen.
• From 11 a.m. to 12 p.m. CST, we’ll examine the logistical challenges of vaccine distribution internationally, including socioeconomic challenges. This panel will also explore misinformation and disinformation as it relates to the vaccines. Panelists include Josh Michaud from the Kaiser Family Foundation and Scott Ratzan from CUNY’s School of Public Health.
A link to the Zoom webinar will be emailed to all registrants prior to the webinar. The webinar will also be live-streamed here: https://www.youtube.com/c/KnightCenterCourses
- 1st Feb, 2021 15:30 - UTC
Join leaders from the World Health Organization for an update on vaccine distribution. Chief Scientist Dr. Souyma Swaminathan will moderate a panel of international experts discussing updates on COVID-19 vaccine distribution on a global scale, including strategies to support equitable vaccine delivery.
- 9th Feb, 2021 18:00 - 19:00 - UTC
Join the International Vaccine Acces Center and the Sabin Vaccine Institute for a webinar presentation about how misinformation spreads over social media platforms and creates vaccine hesitancy. The public’s trust in vaccine safety and effectiveness are key to maintaining immunization coverage and protecting at-risk populations from preventable diseases. Immunization and communications experts will discuss what action is needed to prevent anti-vaccine efforts from spreading over social media networks, and what challenges the infodemic poses to public health efforts internationally.
- 16th Feb, 2021 13:00 - 14:00 - UTC
The Health Campaign Effectiveness Coalition launches the “Test and Learn” series with a research team from the University of Ottawa and Bruyere Research Institute (Canada), University of Medical Sciences (Nigeria), and University of Health and Allied Sciences (Ghana). The team will enhance our understanding of campaign co-delivery and collaboration opportunities by sharing findings from interviews with 26 health campaign managers across immunization, polio, malaria, Vitamin A, and NTDs programs from Cote d’Ivoire, Ethiopia, Ghana, Guyana, Indonesia, Nigeria.
Moderated by David Gittleman of the Alliance for Malaria Prevention, the 25-minute conversation with the research team will be followed by a 5-minute interlude and 30-minute “Learning Salon” where webinar participants submit questions to the panel and discuss potential recommendations and their implications with the research team.
The Test and Learn Series is held in English, French, and Spanish to advance learning, collaboration and communication in critical health campaign issues across different health campaign domains, country leaders, global actors, donors and implementing groups. Hosted by the Health Campaign Effectiveness Program of the Task Force for Global Health this new series will highlight different innovative campaign approaches and delivery models in the coming months.
- 16th Feb, 2021 15:00 - UTC
On Tuesday, February 16, the Sabin Vaccine Institute invites you to join them for an hour-long moderated webinar event comprised of both an expert panel discussion and brief Q&A. The webinar, Lessons Learned from Past Outbreaks – Bridging Interdisciplinary Insights to Strengthen COVID-19 Vaccination Acceptance and Demand, will feature a panel of global, interdisciplinary experts, including applied anthropologists and global health practitioners, to discuss lessons learned from past infectious disease responses. Expert panelists will reflect on how past responses can inform efforts to strengthen global COVID-19 vaccination acceptance.
This moderated conversation with soon to be announced expert panel will discuss the structural and systemic factors historically impacting global health infectious disease programs and place them into conversation with the realities of disease response in practice. Panelists will apply these insights to inform COVID-19 and future vaccination approaches.
You can submit questions for the Q&A component in advance to VaccineAcceptance@sabin.org.
- 18th Feb, 2021 10:00 - 11:30 - UTC
As countries around the world respond to the COVID-19 pandemic, already strained health supply chains are being tested. Empower School of Health and The Pharmaceutical Society of Sierra Leone (PSSL) are hosting a webinar on Strengthening Immunization-Supply chain management and preparing for COVID-19 Vaccines.
The key objectives of this webinar are:
1. Discussing key considerations for a new COVID-19 vaccine introduction in health systems and the associated supply chain requirements and
2. How they might influence the future of supply chains in a post-COVID-19 world.
Register here to join us: http://bit.ly/empower_PSSL_immunization
DATE: 18 February 2021
TIME: 10:00 am-11.30 am Greenwich Mean Time
- Global initiatives
- 22nd Feb, 2021 13:00 - 25th Feb, 2021 05:00 - UTC
GVIRF is the only global meeting that brings together the entire Vaccine and Immunization Research community, from basic immunology to implementation research, and from low to high income countries.
1. Track progress in vaccine research and development
2. Identify gaps, opportunities and actions to maximize the benefit of immunization
3. Foster networking and collaboration to accelerate progress
4. Support implementation of Immunization Agenda 2030
GVIRF 2021 will be:
Influential: Featuring high level keynotes and speakers from the forefront of immunization research
Timely: Reviewing progress in vaccines for COVID-19
Balanced: Discussing COVID-19 in context of overall immunization and relationship with other diseases
Equity-oriented: Aiming to foster global participation and address global needs
To enable active participation regardless of time zone, GVIRF 2021 will be held twice each day. The first block is for participants closer to the prime meridian (UTC +0). The second block is for participants closer to the international date line (UTC +12). Both blocks will have the same content. Please attend the sessions that work best for you.
GVIRF is hosted every two years by World Health Organization, the US National Institutes of Health, and the Bill & Melinda Gates Foundation.
For a full agenda - please go to https://www.gvirf.org
- Sorry, but the event is over and you will no longer be able to RSVP or make any RSVP updates for this event
- 1st Mar, 2021 13:00 - 14:00 - UTC
As part of an ongoing series, Boost members are invited to engage with Bright Spots story submitters through webinars that will highlight promising practices from selected stories. These webinars will provide you with an opportunity to interact with and learn from your peers.
This sixth Bright Spots webinar will feature JSI Pakistan colleagues, as they share their story of addressing barriers to vaccination coverage in the Sindh province in southwestern Pakistan through a new framework with a synergistic approach.
Over the course of the session, the team will share their process and challenges, lessons learned, successes to date and highlight some of his approaches that might be relevant to you in your own work.
- Cold chain equipment
- 11th Mar, 2021 16:00 - 17:00 - UTC
Given the need for an ultra-cold chain (UCC) for an initial leading COVID-19 vaccine candidate, Project Last Mile conducted an analysis on the availability of liquid CO2 (LCO2) within the Coca-Cola value chain in 47 countries in Africa to assist in meeting potential dry ice needs to support ultra-cold chain vaccine distribution. This was then expanded to include COVAX countries in Latin America and the Pacific Islands. Ultimately, Project Last Mile completed a rapid assessment examining the feasibility of procuring LCO2 in 70 countries from Coca-Cola partners and suppliers across the three regions.
The upcoming webinar: Findings on the operational feasibility of maintaining ultra-cold temperatures to distribute COVID-19 vaccines – the availability of dry ice within the Coca-Cola value chain in 70 countries will be held on Thursday, March 11, 2021, at 8:00 am PST (UTC-8 hours). At the following link, you can look up the webinar timing in your local time zone: https://tinyurl.com/38jco5ah.
This webinar will share the culmination of this study. The aim is to contribute significant insights into determining the operational feasibility of maintaining ultra-cold temperatures to distribute COVID-19 vaccines. The findings can also inform where COVID-19 vaccines requiring ultra-cold chain may not be feasible or will require another LCO2 procurement approach.
Project Last Mile (PLM) is an innovative public-private partnership launched in 2010 between The Coca-Cola Company, The Coca-Cola Foundation, United States Agency for International Development (USAID), President’s Emergency Plan for AIDS Relief (PEPFAR), The Global Fund, and Bill & Melinda Gates Foundation to draw private-sector lessons from across the Coca-Cola value chain to benefit health systems strengthening in Africa.
The webinar will be led by Jonathan Halse, who undertook the analysis for Project Last Mile. Jonathan currently leads Supply Chain Redesign Projects across multiple countries in Africa with Project Last Mile. Jonathan has worked for many leading FMCG leadership brands, including Coca-Cola, Mars, and Pepsi, where he held numerous leadership positions in operations and was deeply involved in capability building in many diverse markets across Africa, Asia, and the Middle East. The webinar will be opened by Alexandra Scott, Director of Program Delivery for Project Last Mile.
Time will be dedicated to answering questions from national and sub-national focal points.
If you haven’t yet registered for this event, you can do so here:
The session will build upon the findings in:
We look forward to welcoming you on the call. Please feel free to ask follow-up questions by replying to this post:
- 15th Mar, 2021 14:30 - 15:30 - UTC
All eyes are on the global rollout of COVID-19 vaccines. Over the coming months, vaccine manufacturers, regulatory authorities, logistics experts and healthcare practitioners alike are facing the daunting challenge of delivering billions of vaccine doses around the world and ensuring that every dose remains safe and effective.
Achieving the public confidence and broad uptake of COVID-19 vaccines needed to reach population immunity and curb the virus’s spread will require an unprecedented effort among health workers, scientists and stakeholders at every step of the supply chain.
During development and delivery, how will we guarantee that quality is maintained for authorized and approved vaccines? How will we build and strengthen health system capacity to implement quality vaccination services, especially in LMICs facing insufficient health system resources and inadequate vaccine supply? Finding the solutions to these questions will be a defining challenge of 2021 and a key hurdle to getting vaccines to the people who need them the most. This virtual event will convene two expert panels moderated by Zain Verjee (former CNN International Anchor) with participation from Soumya Swaminathan (WHO), Bruce Gellin (Sabin Vaccine Institute), Ron Piervincenzi (USP) and others from organizations central to the COVID-19 response who will dive into existing concerns and explore novel, future solutions that will bolster public trust in the vaccine effort and help ensure an equitable rollout.
Please submit any questions you may have for the event Q&A in advance to firstname.lastname@example.org.
- 18th Mar, 2021 10:00 - 11:00 - UTC
In collaboration with Common Thread, LNCT captured the vaccination journeys of two families within a H’mong community in Yên Bái Province, Vietnam. Their stories, captured in their own words, show how community engagement strategies can be used effectively to create empathy and build demand for vaccines among vulnerable groups. LNCT and Common Thread are pleased to share these case studies with you at an upcoming launch on Thursday, March 18th. During this video launch webinar, Common Thread will walk participants through the two journeys, reflect on the strategies used in the community, and explore how these materials can be used to build skills to generate demand for vaccines amongst ethnic minorities in other contexts.
Date: March 18, 2021
Time: 6:00-7:15 am EDT / 11:00 am-12:15 pm Abuja / 2:00-3:15 pm Tbilisi / 3:30-4:45 pm New Delhi
Details: This session will be hosted in English, but simultaneous interpretation will be provided live on Zoom in French, Portuguese, and Russian, as needed. If you require interpretation, please confirm which language when you register. We recommend you register by March 12th to ensure interpretation can be arranged in advance.
- 23rd Mar, 2021 15:00 - 16:00 - UTC
The International Vaccine Access Center (IVAC) on March 23, 2021 at 11:00am ET will host a 60-minute webinar SARS-CoV-2 Variants and the Safety of COVID-19 Vaccines in the U.S.
Description: Join us for a special webinar presentation about COVID-19 vaccine safety in the U.S. and the potential impact new variants will have on vaccine effectiveness. The speed and coordination of the response against COVID-19 and development of vaccines is unprecedented, but there are still unknowns and issues to overcome. In a moderated conversation, hear from experts on safety monitoring, reporting, and challenges with emerging variants.
- 25th Mar, 2021 13:30 - 14:30 - UTC
A live webinar organised by CDDEP, in collaboration with the WHO
How can vaccines address the problem with AMR?
Dr. Hanan Balkhy,
Assistant-Director General for AMR, WHO
Deepali Patel MPH, Acting Head, Policy, Gavi
Dr. Padmini Srikantiah,
Senior Program Officer, AMR Strategy Lead
Bill & Melinda Gates Foundation
Dr. Mateusz Hasso-Agopsowicz,
Technical Officer, WHO
Dr. Joseph Lewnard,
Assistant Professor, UC Berkeley
With an introduction from Dr. Ramanan Laxminarayan, Director at CDDEP.
This is part of a webinar series celebrating 10 years of CDDEP, highlighting research on Antimicrobial Resistance, Vaccines, and COVID-19
Note: You can also follow this webinar LIVE on Facebook at: https://m.facebook.com/cddep/live
(this does not require a Facebook account)
- 30th Mar, 2021 12:00 - 13:00 - UTC
Governments and states are encouraged to include all high-risk individuals and populations, according to the WHO SAGE recommendations, independent of their residency and legal status, including internally displaced populations, refugees, migrants and detainees. These populations face specific challenges and vulnerabilities.
This webinar organized by the WHO explores this critical issue, current practices, challenges and solutions through several countries examples.
Please send your questions in advance to email@example.com
- 30th Mar, 2021 14:00 - 15:30 - UTC
EMPHNET is announcing the launch of the next webinar in its WEBi Series titled “Increasing Vaccine Demand and Uptake During the COVID-19 Vaccine Infodemic” The webinar will be held on Tuesday March 30, 2021 from 17:00 to 18:30, Jordan Local Time (UTC+3).
The rapid spread of unverified information in the media triggers harm by building confusion and drowning out accurate health information. It can also cause a change in behavior, amplification of panic and the use of unproven and harmful treatments. Finally, it can lead to negative attitudes to vaccination, and consequently increase the level of vaccine hesitancy among vulnerable populations. This webinar, led by a panel of experts, tackles the infodemic witnessed during the COVID-19 pandemic and the application of effective and actionable approaches that communities, health institutions and authorities can take to promote the flow of accurate health information and that can mitigate the harm that rumors and misinformation can cause.
The webinar session will focus on:
- Exchanging knowledge, best practices, and lessons learned from global and regional infodemic trends and approaches.
- Sharing a real country experience in tackling the COVID-19 infodemic.
- Proposing actionable approaches and strategies to address the COVID-19 infodemic and misinformation.
- Building resilience against misinformation in health systems and the public using available different resources.
Participating experts include:
- Dr. Saad Omer, Director of the Yale Institute for Global Health, and Professor of Medicine and Epidemiology at Yale University, Schools of Medicine and Public Health.
- Dr. Niaz Muhammad, Director General Health Services, Khyber Pakhtunkhwa, Pakistan.
- Mr. AbdelHalim AbdAllah, Crisis Communications Officer for the World Health Organization (WHO) Regional Office for Africa.
The session will be facilitated by Prof. Hyam Nicola Bashour, Professor of Epidemiology and Community Health at Al Sham Private University and Public Health Expert and Mr. Atsuyoshi Ishizumi, Research Fellow at US Centers for Disease Control and Prevention (CDC).
Register here: https://us02web.zoom.us/webinar/register/WN_YM2mdvL8SfmzvwsyAui_5w
- 31st Mar, 2021 13:00 - 14:00 - UTC
The Single-dose HPV Vaccine Evaluation Consortium collates and synthesizes existing evidence and evaluates new data on the potential for single-dose HPV vaccination. Their goal is to inform global policy discussions and program guidance, as well as to raise awareness and understanding of its implications. The Consortium invites you to join a webinar with some of their researchers to review the recently released evidence.
The 31 March session (3-4 PM CET) will provide updates from clinic trials, observational studies, and modeling analyses on the efficacy, immunogenicity, effectiveness, and cost-effectiveness of single dose HPV vaccination. If demonstrated to be effective, single-dose HPV vaccination could facilitate new options for current national programs by simplifying delivery and lowering program costs. For low- and middle-income countries that have delayed introducing HPV vaccines because of financial, logistical or other barriers; a single-dose HPV vaccination schedule could accelerate introduction of HPV vaccines into national immunization schedules.
Kiesha Prem, PhD, Research Fellow, Centre for the Mathematical Modelling of Infectious Diseases, LSHTM
Anne Schuind, MD, Initiative Team Leader for HPV Vaccines, Center for Vaccine Innovation and Access, PATH
Evan Simpson, DrPH, MPH, Team Lead, Vaccine Implementation, Center for Vaccine Innovation and Access, PATH
For resources or to discuss about this topic: https://www.technet-21.org/en/forums/discussions/technet-webinar-new-single-dose-hpv-vaccination-evidence-and-resources